SeekIn Receives CE-IVD Mark Approval for SeekInCure® Cancer Recurrence Monitoring Kit
First-of-its-kind blood-based pan-cancer recurrence monitoring test SHENZHEN, China, Nov. 28, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced CE (Conformité Européenne) Mark approval for SeekInCure® Cancer Recurrence Monitoring Kit and is now ready to launch this test in European Union and other countries that recognize CE-IVD Mark. Cancer recurrence after...
DetectedX Introduces ImageDx to Transform Image-Based Education at RSNA
Showcases Momentum with New Customers, New Subscriber Options and the Addition of Professor László Tabár to the Executive Team CHICAGO, Nov. 28, 2022 /PRNewswire/ -- Building on the successful U.S. launch at the SBI/ACR Breast Imaging Symposium, DetectedX, the leaders in intelligent interactive educational technology, will showcase updates to its Radiology...
IZIon24 – The first pocket insurance app in Vietnam determines to protect millions of people
HO CHI MINH CITY, Vietnam, Nov. 28, 2022 /PRNewswire/ -- Recently, Ideal Life Consultancy Joint Stock Company held a press conference to announce the launch of insurtech product IZIon24 - the very first pocket insurance app in Vietnam. The event had the presence of Mr. Kalidas Ghose - Director of Vietnam Prosperity...
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
SHANGHAI and NEW ORLEANS, Nov. 28, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the preliminary safety and efficacy data from the Phase I study of GFH009 monotherapy for treatment of relapsed/refractory hematological malignancies will be shared at the 2002 Annual Meeting of the American Society of Hematology (ASH)...
OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
LONDON, Nov. 28, 2022 /PRNewswire/ -- OPEN Health, a leading global provider of scientific communication and market access services helping pharmaceutical companies to unlock the full potential of their clinical and commercial assets, majority owned by Astorg, has announced additions to its board of directors, appointing David P. King as non-executive chairman and...
COLOTECT – Non-invasive Colorectal Cancer Screening Test has been launched in Southeast Asia
BANGKOK, Nov. 28, 2022 /PRNewswire/ -- COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and precancerous lesions risk, and detect bowel cancer risk even in the absence of active bleeding lesions, according to BkkGI. Colorectal cancer is the third most...
A new start: Learn, Grow and Thrive at iBHE, Tsinghua SIGS
SHENZHEN, China, Nov. 28, 2022 /PRNewswire/ -- Keer HU, enrolled in the Bioengineering and Translational Medicine program at the Institute of Biopharmaceutical and Health Engineering(iBHE), Tsinghua Shenzhen International Graduate School (SIGS), is a freshman in the class of 2022. Also working on many projects as a young designer, she has won many awards and exhibition invitations at home and...
TELEHEALTH USAGE IN ASIA PACIFIC FOR PEOPLE LIVING WITH HIV INCREASING, BUT DATA PRIVACY AND LACK OF PERSONAL CONTACT STILL SEEN AS A BARRIER TO WIDER USE
- Half of the people living with HIV (PLHIV) and individuals at-risk (IARs) surveyed in the region increased their usage of telehealth services over the past year; this is driven by the availability of new telehealth services during pandemic - Top factor impacting usage of telehealth services for PLHIV is...
Nuance Pharma announces partnership with DKSH to launch Bentrio™ Nasal Spray in Hong Kong and Macau
SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces partnership with DKSH Hong Kong (DKSH HK) Business Unit Healthcare to launch BentrioTM nasal spray in Hong Kong and Macau, marking the very first milestone of Nuance Pharma's commercial expansion in the APAC market. Under the cooperation agreement, DKSH HK will provide full-agency services including key account management, marketing...
Yidu Tech Announces Results for the First Half of FY2023: Adjusted Net Loss Narrowed down 30.3% YoY, Strategic Focus Enhanced Business Resilience
HONG KONG, Nov. 28, 2022 /PRNewswire/ -- Yidu Tech Inc. ("Yidu Tech" or "the Company", together with its subsidiaries and consolidated affiliated entities, "the Group", HKEx: 2158), a leading corporate in China's healthcare intelligence industry, announced the interim results for the six months ended 30 September 2022 ("the first half of FY2023" or "the Reporting Period"). Despite the challenging and uncertain external...
